2024 CME/MOC credit

Claim CME/MOC credit in the Virtual VIVA app

Learn More

The VIVA Foundation Appoints New Board Member

Please join us in welcoming Dr. Kush R. Desai to our Board of Directors

Learn More

Late-Breaking Clinical Trials

First-on-podium data presented at The VEINS & VIVA

Save the date! VIVA and The VEINS return to Wynn Las Vegas next fall.

The VEINS: November 1 - 2, 2025

VIVA: November 2 - 5, 2025

Our Mission

VIVA is driven to improve patient care through multidisciplinary collaboration, drawing leaders from all areas of vascular care to move the field forward.

Learn more

Our Board

VIVA's board represents specialists across the spectrum of interventional cardiology, interventional radiology, vascular medicine, and vascular surgery.

See our Board of Directors and Founders

Claim CME/MOC Credit

Claim credit for attending VIVA and The VEINS 2024 in the Virtual VIVA app

Access Virtual VIVA

News & Updates

Dr. Kush R. Desai Appointed to The VIVA Foundation Board of Directors

December 18, 2024

The VIVA Foundation has appointed Kush R. Desai, MD, FSIR, as the newest member of the Board of Directors. The Foundation is a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education, research, advocacy, and collaboration. Dr. Desai has collaborated with The ...

News & Updates

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

November 5, 2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVentional Advanc ...

News & Updates

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

November 5, 2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVention ...